专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

41. 发明申请

WO2014007697A1 A RADIO NETWORK NODE, A USER EQUIPMENT AND METHODS THEREIN 审中-公开
标题翻译：无线网络节点，用户设备及其方法
公开(公告)号：WO2014007697A1
公开(公告)日：2014-01-09
申请号：PCT/SE2012/050775
申请日：2012-07-04
申请人： TELEFONAKTIEBOLAGET L M ERICSSON (PUBL) , LIAO, Jingyi , WITTBERG, Mikael , ZHAO, Wei
发明人： LIAO, Jingyi , WITTBERG, Mikael , ZHAO, Wei
IPC分类号： H04W36/08
CPC分类号： H04W36/0072 , H04W36/0077 , H04W36/08 , H04W74/0833
摘要： A radio network node(RNN) (202) and a method therein, for handling of changing primary cell from a first cell (204) to a second cell (206) during re-selection of primary cell of a user equipment (UE) (208). The RNN is configured to serve the first cell, the UE is located within the first cell and is served by the RNN, and RNN and the UE are comprised in a communications system (200). The RNN transmits an RRCConnectionReconfiguration signal to the UE, which signal comprises an indication that the UE does not need to perform a random access procedure for the second cell when changing primary cell from the first cell to the second cell.
摘要翻译：一种无线电网络节点（RNN）（202）及其方法，用于在用户设备（UE）的主小区重新选择期间处理从第一小区（204）到第二小区（206）的改变的主小区 208）。 RNN被配置为服务于第一小区，UE位于第一小区内并由RNN服务，并且RNN和UE包括在通信系统（200）中。 RNN向UE发送RRCConnectionReconfiguration信号，该信号包括当将主小区从第一小区改变到第二小区时，UE不需要为第二小区执行随机接入过程的指示。

42. 发明申请

WO2011134959A1 REMOTE N-DOPING OF ORGANIC THIN FILM TRANSISTORS 审中-公开
标题翻译：有机薄膜晶体管的远程N掺杂
公开(公告)号：WO2011134959A1
公开(公告)日：2011-11-03
申请号：PCT/EP2011/056584
申请日：2011-04-26
申请人： UNIVERSITY OF PRINCETON , GEORGIA TECH RESEARCH CORPORATION , SOLVAY SA , ZHAO, Wei , QI, Yabing , KAHN, Antoine , MARDER, Seth , BARLOW, Stephen
发明人： ZHAO, Wei , QI, Yabing , KAHN, Antoine , MARDER, Seth , BARLOW, Stephen
IPC分类号： H01L51/05 , H01L51/00
CPC分类号： H01L51/0067 , B82Y10/00 , H01L51/002 , H01L51/0036 , H01L51/0043 , H01L51/0046 , H01L51/0053 , H01L51/0072 , H01L51/0084 , H01L51/0085 , H01L51/0094 , H01L51/0541 , H01L51/0545 , H01L51/0558 , H01L51/0562
摘要： The inventions disclosed, described, and/or claimed herein relate to organic electronic devices comprising "remotely" doped materials comprising a combination of at least three layers. Such devices can include remotely n-doped structures comprising a combination of at least three layers: a) a channel layer comprising at least one organic semiconductor channel material; b) a dopant layer which comprises at least one organic electron transport material doped with an n-dopant material c) a spacer layer disposed between and in electrical contact with the channel layer and the dopant layer, comprising an organic semiconducting spacer material. The devices of the invention include "remotely doped" field effect transistors comprising the doped structures described above.
摘要翻译：本文公开，描述和/或要求保护的发明涉及包括至少三层组合的“远程”掺杂材料的有机电子器件。这样的器件可以包括远程n掺杂结构，其包括至少三层的组合：a）包含至少一种有机半导体沟道材料的沟道层; b）掺杂剂层，其包含掺杂有n掺杂剂材料的至少一种有机电子传输材料，c）间隔层，其设置在沟道层和掺杂剂层之间并与电子接触，包括有机半导体间隔物材料。本发明的器件包括包含上述掺杂结构的“远掺杂”场效应晶体管。

43. 发明申请

WO2011102774A1 DETECTION OF RADIO LINK FAILURE (RLF) FOR RECOVERY 审中-公开
标题翻译：检测无线电链路故障（RLF）用于恢复
公开(公告)号：WO2011102774A1
公开(公告)日：2011-08-25
申请号：PCT/SE2010/051481
申请日：2010-12-23
申请人： TELEFONAKTIEBOLAGET L M ERICSSON (PUBL) , DIMOU, Konstantinos , LINDSTRÖM, Magnus , ZHAO, Wei
发明人： DIMOU, Konstantinos , LINDSTRÖM, Magnus , ZHAO, Wei
IPC分类号： H04W36/00
CPC分类号： H04W36/0055
摘要： Embodiments herein relate to a method in a user equipment (10) for handling a radio link failure in a radio communications network. The user equipment (10) is served in a first cell (14) controlled by a radio base station (12) and which radio base station (12) is comprised in the radio communications network, The user equipment (10) detects a first indication of a failure of a radio link between the user equipment (10) and the radio base station (12). The user equipment (10) then transmits a second indication of radio link failure to the radio base station (12) when the first indication is detected.
摘要翻译：本文的实施例涉及用于处理无线电通信网络中的无线电链路故障的用户设备（10）中的方法。用户设备（10）被服务在由无线电基站（12）控制的第一小区（14）中，并且该无线电基站（12）包括在无线电通信网络中。用户设备（10）检测第一指示在用户设备（10）和无线电基站（12）之间的无线电链路的故障。当检测到第一指示时，用户设备（10）然后向无线电基站（12）发送无线电链路故障的第二指示。

44. 发明申请

WO2011075491A1 VIA STRUCTURE INTEGRATED IN ELECTRONIC SUBSTRATE 审中-公开
标题翻译：通过集成在电子基板中的结构
公开(公告)号：WO2011075491A1
公开(公告)日：2011-06-23
申请号：PCT/US2010/060362
申请日：2010-12-14
申请人： QUALCOMM Incorporated , LI, Xia , ZHAO, Wei , CAO, Yu , GU, Shiqun , KANG, Seung H. , KING, Ming-Chu
发明人： LI, Xia , ZHAO, Wei , CAO, Yu , GU, Shiqun , KANG, Seung H. , KING, Ming-Chu
IPC分类号： H01L23/552 , H01L23/66 , H01L23/498 , H01L23/48 , H01L23/64 , H05K1/02
CPC分类号： H01L23/552 , H01L23/14 , H01L23/49827 , H01L23/645 , H01L23/66 , H01L2223/6616 , H01L2223/6622 , H01L2223/6638 , H01L2924/0002 , H01L2924/3011 , H05K1/0222 , H05K1/0245 , H05K3/4602 , H05K3/4644 , H05K2201/09809 , Y10T29/49117 , H01L2924/00
摘要： A system of via structures disposed in a substrate. The system includes a first via structure that comprises an outer conductive layer, an inner insulating layer, and an inner conductive layer disposed in the substrate. The outer conductive layer separates the inner insulating layer and the substrate and the inner insulating layer separates the inner conductive layer and the outer conductive layer. A first signal of a first complementary pair passes through the inner conductive layer and a second signal of the first complementary pair passes through the outer conductive layer. In different embodiments, a method of forming a via structure in an electronic substrate is provided.
摘要翻译：设置在基板中的通孔结构的系统。该系统包括第一通孔结构，其包括外导电层，内绝缘层和设置在基板中的内导电层。外部导电层分离内部绝缘层和基板，内部绝缘层分离内部导电层和外部导电层。第一互补对的第一信号通过内导电层，第一互补对的第二信号通过外导电层。在不同的实施例中，提供了一种在电子衬底中形成通孔结构的方法。

45. 发明申请

WO2011002910A1 CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 审中-公开
标题翻译： 11BETA - 羟基脱氢酶脱氢酶的循环抑制剂1
公开(公告)号：WO2011002910A1
公开(公告)日：2011-01-06
申请号：PCT/US2010/040641
申请日：2010-06-30
申请人： VITAE PHARMACEUTICALS, INC. , CLAREMON, David A. , LEFTHERIS, Katerina , SINGH, Suresh B. , TICE, Colin M. , YE, Yuanjie , ZHUANG, Linghang , ZHAO, Wei
发明人： CLAREMON, David A. , LEFTHERIS, Katerina , SINGH, Suresh B. , TICE, Colin M. , YE, Yuanjie , ZHUANG, Linghang , ZHAO, Wei
IPC分类号： C07D265/10 , C07D405/10 , A61K31/535 , A61P3/06 , A61P3/10 , A61P9/12 , A61P19/10 , A61P25/00
CPC分类号： C07D265/10 , C07D413/10
摘要： This invention relates to novel compounds of the Formula (I), (II), (II-A), (Il-B), (ll-C), (ll-D), (III). (III-A). (IIIl-B). (IIl-C). (IIl-D), (III-E) (IV), (IV-A), (IV-B). (IV-C), (IV-D). (V), (V-A), (V-B), (V-C), (V-D), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11β-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of cortisol in a cell or the inhibition of the conversion of cortisone to cortisol in a cell.
摘要翻译：本发明涉及式（I），（II），（II-A），（II-B），（II-C），（II-D），（III）的新化合物。（III-A）。（IIIL-B）。（IIL-C）。（II-D），（III-E）（IV），（IV-A），（IV-B）。（IV-C），（IV-D）。（V），（VA），（VB），（VC），（VD），其药学上可接受的盐及其药物组合物，其可用于治疗与11β-HSD1的调节或抑制相关的疾病哺乳动物。本发明进一步涉及新化合物的药物组合物及其用于减少或控制细胞中皮质醇产生或抑制细胞中可的松转化为皮质醇的方法。

46. 发明申请

WO2009108332A1 INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1 审中-公开
标题翻译： 11β-羟基脱氢酶脱氢酶抑制剂1
公开(公告)号：WO2009108332A1
公开(公告)日：2009-09-03
申请号：PCT/US2009/001215
申请日：2009-02-26
申请人： VITAE PHARMACEUTICALS, INC. , CLAREMON, David, A. , TICE, Colin, M. , YE, Yuanjie , SINGH, Suresh, B. , HE, Wei , ZHAO, Wei , SIMPSON, Robert, D.
发明人： CLAREMON, David, A. , TICE, Colin, M. , YE, Yuanjie , SINGH, Suresh, B. , HE, Wei , ZHAO, Wei , SIMPSON, Robert, D.
IPC分类号： C07D221/20 , C07D471/10 , A61K31/438 , A61P3/00
CPC分类号： C07D471/10 , C07D221/20
摘要： This invention relates to novel compounds of the Formulae I or II and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 β-HSD l in mammals.Formula (I).
摘要翻译：本发明涉及式I或II的新化合物及其药学上可接受的盐及其药物组合物，其可用于治疗与哺乳动物中11β-HSD1的调节或抑制相关的疾病的治疗。方案（I）。

47. 发明申请

WO2009061498A1 CYCLIC UREA INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 审中-公开
标题翻译： 11β-羟基脱氢酶脱氢酶的循环尿素抑制剂1
公开(公告)号：WO2009061498A1
公开(公告)日：2009-05-14
申请号：PCT/US2008/012618
申请日：2008-11-07
申请人： VITAE PHARMACEUTICALS, INC. , CLAREMON, David, A. , ZHUANG, Linghang , TICE, Colin, M. , YE, Yuanjie , HE, Wei , SINGH, Suresh, B. , XU, Zhenrong , CACATIAN, Salvacion , ZHAO, Wei
发明人： CLAREMON, David, A. , ZHUANG, Linghang , TICE, Colin, M. , YE, Yuanjie , HE, Wei , SINGH, Suresh, B. , XU, Zhenrong , CACATIAN, Salvacion , ZHAO, Wei
IPC分类号： C07D239/10 , C07D401/04 , C07D401/10 , C07D403/06 , C07D409/04 , C07D409/10 , C07D417/10 , A61K31/513 , A61K31/5377 , A61P3/00 , A61P27/06 , A61P9/00
CPC分类号： C07D239/10 , C07D401/04 , C07D401/10 , C07D403/06 , C07D409/04 , C07D409/10 , C07D417/10
摘要： This invention relates to novel compounds of the Formula (I), (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih)1 (Ij), (Ik), (II 1-3 ). (Im 1-3 ), (In 1-3 ), (lo 1-2 ), (Ip 1-6 ), (Iq 1-6 ), (Ir 1-6 ) and (Is 1-2 ), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 β-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of Cortisol in a cell or the inhibition of the conversion of cortisone to Cortisol in a cell.
摘要翻译：本发明涉及式（I），（Ia），（Ib），（Ic），（Id），（Ie），（If），（Ig），（Ih） Ik），（II1-3）。（I1-3），（Ⅰ1-3），（lo1-2），（Ⅰp1-6），（Ⅰq1-6），（Ir1-6）和（Is1-2），其药学上可接受的盐和药物组合物其可用于治疗与哺乳动物中11β-HSD1的调节或抑制相关的疾病的治疗。本发明进一步涉及新化合物的药物组合物及其用于减少或控制细胞中皮质醇生产或抑制细胞中可的松转化为皮质醇的方法。

48. 发明申请

WO2009048358A1 AN ARRANGEMENT AND A METHOD FOR HANDLING FAILURES IN A NETWORK 审中-公开
标题翻译：一种安排和处理网络故障的方法
公开(公告)号：WO2009048358A1
公开(公告)日：2009-04-16
申请号：PCT/SE2007/050722
申请日：2007-10-09
申请人： TELEFONAKTIEBOLAGET L M ERICSSON (PUBL) , ZHAO, Wei , KÖLHI, Johan
发明人： ZHAO, Wei , KÖLHI, Johan
IPC分类号： H04L12/24 , H04L12/413 , H04L12/56
CPC分类号： H04L41/0672 , H04L41/0213 , H04L41/0659 , H04L41/0677 , H04L43/0811 , H04L43/10 , H04L45/26 , H04L45/66 , H04L69/40
摘要： The present invention relates to an arrangement comprising an Ethernet carrier network, managed by a management system (100) and comprising a number of levels of management domains, each comprising a number of edge nodes (10, 20, 30, 40) and a number of intermediate nodes (1, 2, 3, 4, 5, 6, 7, 8). Each edge node (10, 20, 30, 40) comprises fault detection of connectivity check messages and fault locating means with holding means (11, 21, 31, 41) adapted to hold path information for the paths to all other edge nodes. A fault detection means of an edge node having detected a fault is adapted to activate edge node fault locating means to locate the fault using the patch information in the edge node holding means to find a first target intermediate node substantially in the middle of the path containing the fault, and to, directly, send a first loop back message to said intermediate node. A response from said intermediate node indicates that the fault is located at the distant portion of the path, no response indicates that the fault is located at the proximate portion of the path. Further loop back messages are sent to consecutively identified intermediate nodes of the respective path portion identified to contain the fault by the respective preceding loop back message until the fault is localized.
摘要翻译：本发明涉及一种包括由管理系统（100）管理并且包括多个级别的管理域的以太网运营商网络的装置，每个管理域包括多个边缘节点（10,20,30,40）和数量的中间节点（1，2，3，4，5，6，7，8）。每个边缘节点（10,20,30,40）包括连接性检查消息的故障检测和具有适于保持用于所有其他边缘节点的路径的路径信息的保持装置（11,21,31,41）的故障定位装置。已经检测到故障的边缘节点的故障检测装置适于激活边缘节点故障定位装置，以使用边缘节点保持装置中的补丁信息来定位故障，以在第故障，并且直接向所述中间节点发送第一循环消息。来自所述中间节点的响应指示故障位于路径的远处，没有响应指示故障位于路径的最近部分。进一步的循环消息被发送到被识别为通过相应的先前循环消息识别为包含故障的相应路径部分的连续标识的中间节点，直到故障被定位为止。

49. 发明申请

WO2008156831A2 RENIN INHIBITORS 审中-公开
标题翻译：雷宁抑制剂
公开(公告)号：WO2008156831A2
公开(公告)日：2008-12-24
申请号：PCT/US2008/007704
申请日：2008-06-20
申请人： VITAE PHARMACEUTICALS, INC. , SMITHKLINE BEECHAM CORPORATION , BALDWIN, John, J. , CACATIAN, Salvacion , CLAREMON, David, A. , DILLARD, Lawrence, W. , FLAHERTY, Patrick, T. , ISHCHENKO, Alexey, V. , JIA, Lanqi , MCGEEHAN, Gerard , SIMPSON, Robert, D , SINGH, Suresh, B. , TICE, Colin, M. , XU, Zhenrong , YUAN, Jing , ZHAO, Wei , ZHUANG, Linghang , ZHANG, Jing
发明人： BALDWIN, John, J. , CACATIAN, Salvacion , CLAREMON, David, A. , DILLARD, Lawrence, W. , FLAHERTY, Patrick, T. , ISHCHENKO, Alexey, V. , JIA, Lanqi , MCGEEHAN, Gerard , SIMPSON, Robert, D , SINGH, Suresh, B. , TICE, Colin, M. , XU, Zhenrong , YUAN, Jing , ZHAO, Wei , ZHUANG, Linghang , ZHANG, Jing
IPC分类号： C07C237/24 , C07C237/32 , A61K31/165 , A61P9/00 , A61P9/04 , A61P9/12
CPC分类号： C07C237/24 , C07C237/32 , C07C2601/08
摘要： The present invention is directed to aspartic protease inhibitors. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors.
摘要翻译：本发明涉及天冬氨酸蛋白酶抑制剂。本发明还涉及包含所公开的天冬氨酸蛋白酶抑制剂的药物组合物。本发明还涉及在有需要的受试者中拮抗一种或多种天冬氨酸蛋白酶的方法，以及使用所公开的天冬氨酸蛋白酶抑制剂治疗受试者中天冬氨酸蛋白酶介导的病症的方法。

50. 发明申请

WO2008156816A3 RENIN INHIBITORS 审中-公开
公开(公告)号：WO2008156816A3
公开(公告)日：2008-12-24
申请号：PCT/US2008/007661
申请日：2008-06-20
申请人： VITAE PHARMACEUTICALS, INC. , BALDWIN, John, J. , CACATIAN, Salvacion , CLAREMON, David, A. , DILLARD, Lawrence, W. , FLAHERTY, Patrick, T. , ISHCHENKO, Alexey, V. , JIA, Lanqi , MCGEEHAN, Gerard , SIMPSON, Robert, D. , SINGH, Suresh, B. , TICE, Colin, M. , XU, Zhenrong , YUAN, Jing , ZHAO, Wei , ZHUANG, Linghang
发明人： BALDWIN, John, J. , CACATIAN, Salvacion , CLAREMON, David, A. , DILLARD, Lawrence, W. , FLAHERTY, Patrick, T. , ISHCHENKO, Alexey, V. , JIA, Lanqi , MCGEEHAN, Gerard , SIMPSON, Robert, D. , SINGH, Suresh, B. , TICE, Colin, M. , XU, Zhenrong , YUAN, Jing , ZHAO, Wei , ZHUANG, Linghang
IPC分类号： C07C275/14 , C07C275/16 , C07C275/24 , C07D209/46 , C07D307/88 , C07D307/94 , C07D309/04 , C07D313/04 , A61K31/17 , A61K31/351 , A61K31/335 , A61K31/352 , A61K31/343 , A61K31/4035 , A61P9/00
摘要： The present invention is directed to aspartic protease inhibitors. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式